
UNH
- Market cap
- $472B
- Sector
- Health care

UnitedHealth is two businesses under one roof. UnitedHealthcare sells insurance to employers, individuals and, through Medicare Advantage, to people over 65; Optum delivers the care, runs the pharmacy benefit manager and sells data services, frequently to the insurer's own members. A medical cost that hurts one half can be revenue for the other. The medical loss ratio — the share of premium paid back out as care — is the figure the whole company is read through.
The description is the data provider's own company profile, passed through as it is published and not dated. Where it states a headcount, a list of divisions or an address, the dated figures in the key facts are the ones to read.
UnitedHealth Group Incorporated · Health care · Managed health care
The enterprise value is one period's figure (at 9 Sep 2026), built from a market capitalisation of $472B at $512.60 per share. It is never today's.
Every figure carries its own date: the market capitalisation is the quote's, the share count is current only as of the date its source states, and the employee count is the one reported for its period. The beta is an estimate, with its method, and is never called the company's beta.
Where the shares trade and how they are identified, from the data provider's company profile. The currency is the one the listing trades in, not the one the company reports in. The industry classification is the standard industrial classification code the company files under, where it is held.
| Product line | Share of revenue | Revenue |
|---|---|---|
| UnitedHealthcare | 64% | |
| Optum Rx | 19% | |
| Optum Health | 15% | |
| Optum Insight | 2% |
Revenue by product line and by region for the fiscal year ending 31 Dec 2025, as the company reports its segments. Shares are of the year's reported revenue, never of the segments' sum.
| Region | Share of revenue | Revenue |
|---|---|---|
| United States | 96% | |
| Other countries | 4% |
Revenue by product line and by region for the fiscal year ending 31 Dec 2025, as the company reports its segments. Shares are of the year's reported revenue, never of the segments' sum.
| Officer | Role | Since |
|---|---|---|
| Stephen J. Hemsley | Chief Executive Officer | 2025 |
| Wayne S. DeVeydt | Chief Financial Officer | 2025 |
The executives the data provider lists for the company, with the year each took the role where it is stated. No pay figures are shown.
The latest dividend and its dates, and every stock split on record, as the data provider lists them.
| Period | Employees | Change |
|---|---|---|
| FY2021 | — | |
| FY2022 | +14.3% | |
| FY2023 | +10.0% | |
| FY2024 | +0.0% | |
| FY2025 | −9.1% |
Employees at each fiscal year end, as the company reports them in its annual filing.
The companies the peer comparison sets this one against, each a link to its own research page.